682 related articles for article (PubMed ID: 11651567)
1. Protecting research subjects after consent: the case for the "research intermediary.
Reiser SJ; Knudson P
IRB; 1993; 15(2):10-1. PubMed ID: 11651567
[No Abstract] [Full Text] [Related]
2. Obtaining "informed consent": controversy over radiation tests focuses attention on rules for human subjects.
Wheeler DL
Chron High Educ; 1994 Jan; 40():8-9, 16. PubMed ID: 11658067
[No Abstract] [Full Text] [Related]
3. Power, advocacy, and informed consent forms.
Smith ML
J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
[No Abstract] [Full Text] [Related]
4. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
5. Research subject loses case against physician, IRB, and hospital.
Maloney DM
Hum Res Rep; 1995 Feb; 10(2):4-5. PubMed ID: 11654160
[No Abstract] [Full Text] [Related]
6. Annual review: observed deficiencies and suggested corrections.
Adams MS; Conrad DA
IRB; 1996; 18(6):1-4. PubMed ID: 11654743
[No Abstract] [Full Text] [Related]
7. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
8. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
9. Bill of rights for research subjects.
Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A
IRB; 1993; 15(2):7-9. PubMed ID: 11651568
[No Abstract] [Full Text] [Related]
10. Informed consent process is deemed "legally and ethically invalid" by witness.
Maloney DM
Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
[No Abstract] [Full Text] [Related]
11. Informed consent in psychiatric research.
Roth LH; Appelbaum PS; Lidz CW; Benson P; Winslade WJ
Rutgers Law Rev; 1987; 39(2-3):425-41. PubMed ID: 11659013
[No Abstract] [Full Text] [Related]
12. IRB review of adverse events in investigational drug studies.
Prentice ED; Gordon B
IRB; 1997; 19(6):1-4. PubMed ID: 11656910
[No Abstract] [Full Text] [Related]
13. Neurobiological research involving human subjects: perspectives from the Office for Protection from Research Risks.
Puglisi JT; Ellis GB
Account Res; 1996; 4(3-4):261-5. PubMed ID: 11654521
[No Abstract] [Full Text] [Related]
14. The ethics of involving psychiatrically impaired persons in research.
DeRenzo EG
IRB; 1994; 16(6):7-9, 11. PubMed ID: 11659990
[No Abstract] [Full Text] [Related]
15. Informed consent to participate in research: Part II.
Levine RJ
Bioethics Dig; 1977 Apr; 1(12):1-16. PubMed ID: 11664810
[No Abstract] [Full Text] [Related]
16. Informed consent process and document is criticized in court.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
[No Abstract] [Full Text] [Related]
17. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
18. NZ medicine after Cartwright.
Gillett G
BMJ; 1990 Apr; 300(6729):892-4. PubMed ID: 11642768
[No Abstract] [Full Text] [Related]
19. The regulation of human experimentation in the United States--a personal odyssey.
Katz J
IRB; 1987; 9(1):1-6. PubMed ID: 11649890
[No Abstract] [Full Text] [Related]
20. Changing federal regulation of IRB's: the Commission's recommendations and the FDA's proposals.
Levine RJ
IRB; 1979 Mar; 1(1):1-3+. PubMed ID: 11662736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
